Doxycycline 100-200mg capsules daily for 6 months (DrugBank: Doxycycline)
15 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
13 | 多発性硬化症/視神経脊髄炎 | 0 |
23 | プリオン病 | 0 |
28 | 全身性アミロイドーシス | 0 |
46 | 悪性関節リウマチ | 0 |
84 | サルコイドーシス | 0 |
85 | 特発性間質性肺炎 | 0 |
89 | リンパ脈管筋腫症 | 0 |
96 | クローン病 | 0 |
97 | 潰瘍性大腸炎 | 0 |
158 | 結節性硬化症 | 0 |
162 | 類天疱瘡(後天性表皮水疱症を含む。) | 0 |
167 | マルファン症候群 | 1 |
227 | オスラー病 | 0 |
280 | 巨大動静脈奇形(頚部顔面又は四肢病変) | 0 |
299 | 嚢胞性線維症 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01949233 (ClinicalTrials.gov) | October 2013 | 6/8/2013 | The Oxford Marfan Trial | A Randomised, Double-blind, Placebo-controlled Pilot Trial of Irbesartan, Doxycycline and a Combination on Markers of Vascular Dysfunction in the Marfan Syndrome, Using Cardiovascular Magnetic Resonance Imaging | Marfan Syndrome | Drug: Irbesartan 150-300mg capsules daily for 6 months;Drug: Doxycycline 100-200mg capsules daily for 6 months;Drug: Doxycycline placebo capsules daily for 6 months;Drug: Irbesartan placebo capsules daily for 6 months | University of Oxford | Oxford University Hospitals NHS Trust | Recruiting | 13 Years | N/A | Both | 56 | Phase 2 | United Kingdom |